CVS HEALTH CORPORATION (DE)
Reported by Lehman & Derafelo Financial Resources LLC
Reported 108,233 shares, down 1,609 (1.5%) from the prior quarter.
Reported value -3.7%; share count -1.5% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2019-09-30 | 6830000 |
| 2019-12-31 | 8072000 |
| 2020-03-31 | 6569000 |
| 2020-06-30 | 7229000 |
| 2020-09-30 | 6895000 |
| 2020-12-31 | 7860000 |
| 2021-03-31 | 8663000 |
| 2021-06-30 | 9509000 |
| 2021-09-30 | 9612000 |
| 2021-12-31 | 11523000 |
| 2022-03-31 | 11207000 |
| 2022-06-30 | 10261000 |
| 2022-09-30 | 10476000 |
| 2022-12-31 | 10086208 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2022 | Reduced | 108,233 | -1,609 (-1.5%) | 2.99% | $10,086,208 | 2023-01-20 | |
| Q3 2022 | Reduced | 109,842 | -900 (-0.8%) | 3.3% | $10,476,000 | 2022-10-21 | |
| Q2 2022 | Added | 110,742 | +9 (0.0%) | 3.17% | $10,261,000 | 2022-07-19 | |
| Q1 2022 | Reduced | 110,733 | -971 (-0.9%) | 3.12% | $11,207,000 | 2022-04-21 | |
| Q4 2021 | Reduced | 111,704 | -1,564 (-1.4%) | 3.48% | $11,523,000 | 2022-02-11 | |
| Q3 2021 | Reduced | 113,268 | -690 (-0.6%) | 3.12% | $9,612,000 | 2021-10-28 | |
| Q2 2021 | Reduced | 113,958 | -1,189 (-1.0%) | 2.6% | $9,509,000 | 2021-07-19 | |
| Q1 2021 | Added | 115,147 | +61 (0.1%) | 2.43% | $8,663,000 | 2021-04-21 | |
| Q4 2020 | Reduced | 115,086 | -2,971 (-2.5%) | 2.35% | $7,860,000 | 2021-01-20 | |
| Q3 2020 | Added | 118,057 | +6,790 (6.1%) | 2.19% | $6,895,000 | 2020-11-06 | |
| Q2 2020 | Added | 111,267 | +544 (0.5%) | 2.52% | $7,229,000 | 2020-07-30 | |
| Q1 2020 | Added | 110,723 | +2,070 (1.9%) | 2.73% | $6,569,000 | 2020-05-13 | |
| Q4 2019 | Added | 108,653 | +358 (0.3%) | 2.9% | $8,072,000 | 2020-02-12 | |
| Q3 2019 | New | 108,295 | +108,295 (0.0%) | 2.61% | $6,830,000 | 2019-11-12 |
Who else reported the position
2522 managers reported CVS HEALTH CORPORATION (DE) for Q4 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Added | 117,533,372 | +1,598,531 | 0.3% | $10,952,934,937 | 39 qtrs |
| BlackRock Inc | Added | 94,974,082 | +1,123,455 | 0.28% | $8,850,634,658 | 39 qtrs |
| STATE STREET CORPORATION | Reduced | 57,879,303 | -465,425 | 0.32% | $5,393,772,247 | 39 qtrs |
| Capital World Investors | Reduced | 56,539,787 | -4,356,976 | 1.12% | $5,268,964,189 | 14 qtrs |
| MORGAN STANLEY | Added | 33,576,388 | +3,311,928 | 0.36% | $3,128,983,798 | 39 qtrs |
| JPMorgan Chase & Co | Added | 26,693,891 | +781,358 | 0.33% | $2,487,604,000 | 39 qtrs |
| Capital International Investors | Added | 26,049,978 | +142,488 | 0.65% | $2,427,616,819 | 39 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 23,331,098 | -43,323 | 0.3% | $2,170,273,000 | 39 qtrs |
| Arete Wealth Advisors LLC | Reduced | 19,824 | -1,103 | 0.16% | $1,847,362,910 | 17 qtrs |
| Bank of America Corporation | Reduced | 18,395,814 | -527,361 | 0.2% | $1,714,305,954 | 39 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2022
- Filed
- January 20, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 108,233
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.